The Risk of Presarcopenia Is Increased Among Female Patients With Primary Sjögren's Syndrome.
Journal
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
ISSN: 1536-7355
Titre abrégé: J Clin Rheumatol
Pays: United States
ID NLM: 9518034
Informations de publication
Date de publication:
01 Jan 2022
01 Jan 2022
Historique:
pubmed:
19
12
2020
medline:
28
12
2021
entrez:
18
12
2020
Statut:
ppublish
Résumé
Sarcopenia is a progressive and generalized loss of muscle mass and function. The aim of this study was to evaluate the frequency of sarcopenia among patients with primary Sjögren's syndrome (SS) and the factors related with sarcopenia. Forty-four female patients with primary SS and 44 female control subjects were included in this cross-sectional study between February and August 2019. Sarcopenia was evaluated by the handgrip test, Skeletal Muscle Mass Index, and gait speed test. Eleven patients (25.0%) had presarcopenia in the SS group and 2 (4.5%) in the control group (p = 0.007). Compared with control subjects, SS patients had lower results of hand grip and gait speed tests (p = 0.005 and p < 0.001, respectively). According to the Mini Nutritional Assessment Short Form, patients with presarcopenia had higher risk of malnutrition compared with patients without sarcopenia (p = 0.043). Patients with presarcopenia had higher scores in the European League Against Rheumatism Sjögren's Syndrome Patient-Reported Index pain domain and patient visual analog scale for global disease activity compared with patients without sarcopenia (p = 0.044 and p = 0.036, respectively). In multivariate regression analysis, European League Against Rheumatism Sjögren's Syndrome Patient-Reported Index pain was associated with hand grip strength (p = 0.016, R2 = 0.13) and Mini Nutritional Assessment Short Form was associated with Skeletal Muscle Mass Index (p = 0.005). Risk of sarcopenia is increased in patients with SS. Pain and malnutrition may contribute to presarcopenia. Evaluating pain and patient's global disease activity may help physicians to determine patients with increased risk of sarcopenia. Controlling disease activity and pain and preventing malnutrition may reduce the risk of development of sarcopenia.
Identifiants
pubmed: 33337813
doi: 10.1097/RHU.0000000000001669
pii: 00124743-202201000-00039
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e161-e165Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al., European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing . 2010;39:412–423.
Visser M, Schaap LA. Consequences of sarcopenia. Clin Geriatr Med . 2011;27:387–399.
Bianchi L, Abete P, Bellelli G, et al. Prevalence and clinical correlates of sarcopenia, identified according to the EWGSOP definition and diagnostic algorithm, in hospitalized older people: the GLISTEN study. J Gerontol A Biol Sci Med Sci . 2017;72:1575–1581.
Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing . 2019;48:16–31.
Kizilarslanoglu MC, Kuyumcu ME, Yesil Y, et al. Sarcopenia in critically ill patients. J Anesth . 2016;30:884–890.
Walrand S, Boirie Y. Optimizing protein intake in aging. Curr Opin Clin Nutr Metab Care . 2005;8:89–94.
Brito-Zerón P, Baldini C, Bootsma H, et al. Sjögren syndrome. Nat Rev Dis Primers . 2016;2:16047.
Nocturne G, Mariette X. Sjögren syndrome–associated lymphomas: an update on pathogenesis and management. Br J Haematol . 2015;168:317–327.
Fuggle N, Shaw S, Dennison E, et al. Sarcopenia. Best Pract Res Clin Rheumatol . 2017;31:218–242.
Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis . 2017;76:9–16.
Bahat G, Tufan A, Tufan F, et al. Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition. Clin Nutr . 2016;35:1557–1563.
Sarikaya D, Halil M, Kuyumcu ME, et al. Mini nutritional assessment test long and short form are valid screening tools in Turkish older adults. Arch Gerontol Geriatr . 2015;61:56–60.
Seror R, Ravaud P, Bowman SJ, et al. EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome. Ann Rheum Dis . 2010;69:1103–1109.
Seror R, Ravaud P, Mariette X, et al. EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome. Ann Rheum Dis . 2011;70:968–972.
Díaz-López C, Geli C, Corominas H, et al. Are there clinical or serological differences between male and female patients with primary Sjögren's syndrome? J Rheumatol . 2004;31:1352–1355.
Omdal R, Mellgren SI, Norheim KB. Pain and fatigue in primary Sjögren's syndrome. Rheumatology (Oxford) . 2019;kez027.
de Freitas MM, de Oliveira VLP, Grassi T, et al. Difference in sarcopenia prevalence and associated factors according to 2010 and 2018 European consensus (EWGSOP) in elderly patients with type 2 diabetes mellitus. Exp Gerontol . 2020;132:110835.
Savas S, Taşkiran E, Sarac FZ, et al. A cross-sectional study on sarcopenia using EWGSOP1 and EWGSOP2 criteria with regional thresholds and different adjustments in a specific geriatric outpatient clinic. Eur Geriatr Med . 2020;11:239–246.
Petermann-Rocha F, Chen M, Gray SR, et al. New versus old guidelines for sarcopenia classification: what is the impact on prevalence and health outcomes? Age Ageing . 2020;49:300–304.
Traub J, Bergheim I, Eibisberger M, et al. Sarcopenia and liver cirrhosis—comparison of the European Working Group on Sarcopenia Criteria 2010 and 2019. Nutrients . 2020;12:547.
Zhong S, Chen C, Thompson L. Sarcopenia of ageing: functional, structural and biochemical alterations. Rev Bras Fisioter . 2007;11:91–97.
Vianna LC, Oliveira RB, Araújo CGS. Age-related decline in handgrip strength differs according to gender. J Strength Cond Res . 2007;21:1310–1314.
Scott D, Blizzard L, Fell J, et al. Prospective study of self-reported pain, radiographic osteoarthritis, sarcopenia progression, and falls risk in community-dwelling older adults. Arthritis Care Res . 2012;64:30–37.
Tanishima S, Hagino H, Matsumoto H, et al. Association between sarcopenia and low back pain in local residents prospective cohort study from the GAINA study. BMC Musculoskelet Disord . 2017;18:452.
van Rijn-Dekker MI, van den Bosch L, van den Hoek JGM, et al. Impact of sarcopenia on survival and late toxicity in head and neck cancer patients treated with radiotherapy. Radiother Oncol . 2020;147:103–110.
Azzolino D, Passarelli PC, De Angelis P, et al. Poor oral health as a determinant of malnutrition and sarcopenia. Nutrients . 2019;11:2898.
Affoo RH, Foley N, Garrick R, et al. Meta-analysis of salivary flow rates in young and older adults. J Am Geriatr Soc . 2015;63:2142–2151.
Scully C. Drug effects on salivary glands: dry mouth. Oral Dis . 2003;9:165–176.
Hämäläinen P, Rantanen T, Keskinen M, et al. Oral health status and change in handgrip strength over a 5-year period in 80-year-old people. Gerodontology . 2004;21:155–160.